Searched for
UNIMARK REMEDIES
Bankruptcy court admits BSE-listed Supha Pharmachem under Insolvency Resolution ProcessThe Mumbai bench of the National Company Law Tribunal has admitted Supha Pharmachem into the Corporate Insolvency Resolution Process (CIRP)...- Bankruptcy Court approves listed-firm parental drugs India’s acquisition by IHL LifescienceThe Mumbai bankruptcy court has approved IHL Lifesciences' acquisition of Parental Drugs India Ltd. The resolution plan received 100% appro...
- Bankruptcy court approves Intas-Shamrock plan for Unimark RemediesThe Mumbai bench of the National Company Law Tribunal (NCLT), comprising judicial member Kishore Vemulapalli and technical member Prabhat K...
- Bionpharma buys 25 products from specialty drug maker Banner Life SciencesThe combined revenue of the acquired products is estimated at more than $70 million and forms a mix of high-potency steroidal, antiviral, e...
- USFDA issues warning letter to Mumbai company Unimark RemediesUSFDA has issued a warning letter to Unimark Remedies for violating current good manufacturing practice norms at its plant near in Gujarat.
- CVCI buyout helps Rohatyn with India investmentsSale is part of Citigroup’s move to comply with the Volcker Rule mandating banks to exit their alternative investments.
- Jordan's Hikma in talks to buy 30% in Unimark RemediesJordan-based Hikma Pharmaceuticals is in negotiations to buy 30% stake in Mumbai-based Unimark Remedies, two people familiar with the matte...
- Pharma cos hit by new Patent Act concoction, filings drop 41%Patent applications filed by Indian pharma firms have witnessed a sharp fall of 41% during FY08.
- Bulk drug cos halve output on soaring ingredient costsFaced with a short supply and sharp increase in cost of raw materials imported from China, bulk drug manufactures in India have started sca...
- CVC buys 7% stake in Shiv-Vani Oil for Rs 100 CrGlobal private equity major Citi Venture Capital (CVC) has picked up nearly 7% stake in Delhi-based oil and gas company Shiv-Vani Oil and G...
- CRAMS cos buck pharma trend, give good returnsThe pharma sector may have underperformed the Sensex , but companies providing contract research and manufacturing services (CRAMS) to glob...
- Citi Venture buys 27 pc in Unimark Remedies for Rs 113 crUS private equity fund, Citi Venture Capital, on Wednesday said it has picked up a 27-per cent stake in pharma firm Unimark Remedies for Rs...
- Citi Venture picks up 30% in UnimarkUS-based PE fund Citi Venture Capital has picked up 30% stake in Mumbai-based bulk drug maker Unimark Remedies for Rs 113 crore.
Load More
